DaTscan
Drug
GE Healthcare
Total Payments
$224,851
Transactions
103
Doctors
28
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $91,981 | 21 | 4 |
| 2023 | $56,998 | 5 | 2 |
| 2022 | $1,392 | 76 | 22 |
| 2020 | $74,480 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $200,490 | 13 | 89.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,104 | 5 | 4.9% |
| Consulting Fee | $9,500 | 7 | 4.2% |
| Food and Beverage | $1,392 | 76 | 0.6% |
| Space rental or facility fees (teaching hospital only) | $1,250 | 1 | 0.6% |
| Travel and Lodging | $1,115 | 1 | 0.5% |
Payments by Type
Research
$200,490
13 transactions
General
$24,361
90 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| PARKINSON'S PROGRESSION MARKERS INITIATIVE | GE Healthcare | $74,480 | 0 |
| Dementia Study | GE HEALTHCARE | $67,821 | 0 |
| DAT-17-03: Dementia with Lewy Bodies Consortium | GE HEALTHCARE | $52,468 | 0 |
| Rhode Island Hospital_IST-DAT-23-02_GE-001_IIT | GE HEALTHCARE | $3,888 | 0 |
Ad
Manufacturing Companies
- GE HEALTHCARE $148,979
- GE Healthcare $74,480
- GE HealthCare $1,392
Product Information
- Type Drug
- Total Payments $224,851
- Total Doctors 28
- Transactions 103
About DaTscan
DaTscan is a drug associated with $224,851 in payments to 28 healthcare providers, recorded across 103 transactions in the CMS Open Payments database. The primary manufacturer is GE Healthcare.
Payment data is available from 2020 to 2024. In 2024, $91,981 was paid across 21 transactions to 4 doctors.
The most common payment nature for DaTscan is "Unspecified" ($200,490, 89.2% of total).
DaTscan is associated with 4 research studies, including "PARKINSON'S PROGRESSION MARKERS INITIATIVE" ($74,480).